MedTrace Logo

Making Sense of Dyspnea Assessment

NCT02771262 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 148

Last updated 2020-05-28

No results posted yet for this study

Summary

Dyspnea, or uncomfortable labored breathing, is an important patient-reported outcome (PRO). It is the primary and most disabling symptom of chronic obstructive pulmonary disease (COPD). There is a high priority to improve dyspnea PRO assessment and predict exacerbations. Frequent exacerbations are associated with increased disability, decreased quality of life (QOL), and accelerated lung function decline.

Goals: To test the relative sensitivity to change, responsiveness and predictive validity of a comprehensive dyspnea outcome computer adaptive test (CAT) that measures new anxiety and activity avoidance domains and is more efficient to administer than existing dyspnea scales.

Expected Outcomes: Investigators expect to:

1. begin to transform how dyspnea is assessed;
2. improve dyspnea symptom management;
3. impact functional status;
4. improve QOL;
5. facilitate the earlier treatment and prevention of exacerbations;
6. improve COPD prognosis and survival; and
7. improve COPD healthcare utilization.

Conditions

Interventions

OTHER

Pulmonary Rehabilitation

Sponsors & Collaborators

  • Boston University

    collaborator OTHER

  • VA Boston Healthcare System

    collaborator FED

  • National Institute on Disability, Independent Living, and Rehabilitation Research

    collaborator FED

  • NYU Langone Health

    lead OTHER

Principal Investigators

  • Anna M Norweg, MD · NYU Langone Health

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2019-08-02
Completion
2020-02-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02771262 on ClinicalTrials.gov